【摘要】 随机将６０例脑梗塞患者分成两组，分别采用东菱克栓酶（ＤＦ—５２１）及脉络宁治疗，检测两组治疗前后的血液流变学指标变化并观察临床疗效。结果：治疗组总有效率７６．７％，对照组总有效率４３．３％，两组差别有显著性（Ｐ＜０．０１）；且ＤＦ—５２１有降低血液粘稠度及纤维蛋白原的作用。结论：ＤＦ—５２１是治疗脑梗塞的理想药物，早期使用可提高疗效，改善预后更多还原

【Abstract】 ?This paper reports that sixty cases with cerebral infarction were randomly divided into two groups of thirty Both groups were respectively given Batroxobin(DF-521)and Mailuoning for treatment.Hemorheological changes of patients with cerebral infarction were detected before and after the treatment.Results:The effective rates in the two groups were 76.7% and 43.3%,respectively.Significantly higher therapeutic effect was produced on the DF-521 group than on the Mailuoning group (P<001),and DF-521 can decrease viscosity and fibric degradation production. Conclusion:DF-521 is an effective drug in treating cerebral infarction.更多还原